REVIEW
Accepted on 11 Jul 2025
Critical dysregulated signaling pathways in drug resistance: Highlighting the repositioning of mebendazole for cancer therapy
doi 10.3389/fphar.2025.1631419
- 268 views
1,549
Total downloads
8,364
Total views and downloads
REVIEW
Accepted on 11 Jul 2025
BRIEF RESEARCH REPORT
Accepted on 07 Jul 2025
ORIGINAL RESEARCH
Published on 30 Apr 2025
BRIEF RESEARCH REPORT
Published on 19 Feb 2025
ORIGINAL RESEARCH
Published on 29 Jan 2025
ORIGINAL RESEARCH
Published on 14 Nov 2024